phenylacetyl disulfide: structure in first source
ID Source | ID |
---|---|
PubMed CID | 3378603 |
CHEMBL ID | 4646844 |
SCHEMBL ID | 200592 |
MeSH ID | M0499141 |
Synonym |
---|
c16h14o2s2 |
CBDIVE_012388 |
phenylacetyl disulfide, 96% |
phenylacetyl disulfide |
2-phenylacetic dithioperoxyanhydride |
15088-78-5 |
A809085 |
s-(2-phenylacetyl)sulfanyl 2-phenylethanethioate |
FT-0601957 |
AKOS015889648 |
bis(phenylacetyl) disulphide |
SCHEMBL200592 |
AC-26787 |
B3623 |
bis(phenylacetyl) disulfide |
mfcd00513572 |
J-008754 |
DS-6359 |
disulfide, bis(phenylacetyl) |
D70385 |
CHEMBL4646844 |
CS-0044811 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1651242 | Drug metabolism in PBS buffer assessed as formation of sulfane sulfur from acylated-persulfide intermediate at pH 7.4 in presence of 25 uM CTAB by SSP-4 probe based fluorescence assay | 2020 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4 | Diacyl disulfides as the precursors for hydrogen persulfide (H |
AID1651247 | Drug metabolism in THF assessed as release of hydrogen disulphide in presence of ethane-1,2-diamine by DSP-3 probe based fluorescence assay | 2020 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4 | Diacyl disulfides as the precursors for hydrogen persulfide (H |
AID1651241 | Stability of compound in THF incubated at room temperature | 2020 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4 | Diacyl disulfides as the precursors for hydrogen persulfide (H |
AID1651240 | Stability of compound in DCM incubated at room temperature | 2020 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4 | Diacyl disulfides as the precursors for hydrogen persulfide (H |
AID1651239 | Stability of compound assessed as compound decomposition at 4 degree C measured after 3 weeks | 2020 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4 | Diacyl disulfides as the precursors for hydrogen persulfide (H |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.11) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |